These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 10499612

  • 1. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM, Gaynon PS, Stram DO, Sensel MG, Sarquis MB, Lazarus KH, Willoughby M.
    Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
    [Abstract] [Full Text] [Related]

  • 2. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM, Stork L, Seibel N, Sarquis M, Bedros C, Sather H, Sensel M, Reaman GH, Gaynon PS.
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM, Gaynon PS, Stram DO, Sensel MG, Sarquis MB, Willoughby M.
    Leuk Lymphoma; 2001 Jan; 40(3-4):279-85. PubMed ID: 11426549
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 5. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.
    Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK.
    N Engl J Med; 1993 Oct 28; 329(18):1296-301. PubMed ID: 8413410
    [Abstract] [Full Text] [Related]

  • 6. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
    Unal S, Yetgin S, Cetin M, Gümrük F, Arslan D, Ozyürek E, Tuncer M, Topçu M.
    Pediatr Hematol Oncol; 2004 Oct 28; 21(3):279-89. PubMed ID: 15202168
    [Abstract] [Full Text] [Related]

  • 7. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S.
    Circulation; 2004 Apr 06; 109(13):1615-22. PubMed ID: 15037527
    [Abstract] [Full Text] [Related]

  • 8. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
    Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, Park CJ, Chi HS, Lee MS, Yun S, Lee JS, Lee KH.
    Haematologica; 2005 Oct 06; 90(10):1380-8. PubMed ID: 16219575
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.
    J Clin Oncol; 2005 Nov 01; 23(31):7942-50. PubMed ID: 16258094
    [Abstract] [Full Text] [Related]

  • 10. Outcome of very late relapse in children with acute lymphoblastic leukemia.
    Rizzari C, Valsecchi MG, Aricò M, Miniero R, Messina C, De Rossi G, Testi AM, Mura R, Galimberti S, Biondi A, Locatelli F, Conter V.
    Haematologica; 2004 Apr 01; 89(4):427-34. PubMed ID: 15075076
    [Abstract] [Full Text] [Related]

  • 11. Radiobiological features of fresh leukemic bone marrow progenitor cells in acute lymphoblastic leukemia.
    Uckun FM, Song CW.
    Cancer Res; 1988 Oct 15; 48(20):5788-95. PubMed ID: 3262412
    [Abstract] [Full Text] [Related]

  • 12. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
    Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL.
    J Clin Oncol; 2003 Oct 01; 21(19):3616-22. PubMed ID: 14512392
    [Abstract] [Full Text] [Related]

  • 13. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM, Kersey JH, Haake R, Weisdorf D, Ramsay NK.
    Blood; 1992 Feb 15; 79(4):1094-104. PubMed ID: 1531306
    [Abstract] [Full Text] [Related]

  • 14. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
    Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G.
    N Engl J Med; 1990 Aug 16; 323(7):448-55. PubMed ID: 2095753
    [Abstract] [Full Text] [Related]

  • 15. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov 16; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 16. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
    Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF.
    N Engl J Med; 1997 Jan 30; 336(5):317-23. PubMed ID: 9011783
    [Abstract] [Full Text] [Related]

  • 17. [Bone marrow relapse in high-risk pediatric patients with acute lymphoblastic leukemia: a comparison of relapse times and initial clinical features of patients on different protocols. Children's Cancer and Leukemia Study group (CCLSG)].
    Tsurusawa M, Katano N, Hirota T, Koizumi S, Asami K, Chin M, Ota S, Kawakami T, Hatae Y, Sekine I, Iwai A, Anami K, Nishi K, Miyake M, Watanabe A, Yatabe M, Kawakami K, Gushi K, Yokota S, Gusiken T, Kikuta A, Mimaya J, Okada N, Iga M, Fujimoto T.
    Rinsho Ketsueki; 1998 Aug 30; 39(8):565-73. PubMed ID: 9785974
    [Abstract] [Full Text] [Related]

  • 18. Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic.
    Eckert C, Einsiedel HG, Hartmann R, von Stackelberg A, Völpel S, Guggemos A, Hanzsch N, Kawan L, Seeger K, Henze G.
    Haematologica; 2004 Jul 30; 89(7):ECR23. PubMed ID: 15257960
    [Abstract] [Full Text] [Related]

  • 19. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K, Laws HJ, Meisel R, Traeger A, Bernbeck B, Schonberger S, Stackelberg VA, Pape H, Dilloo D.
    Haematologica; 2006 May 30; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.
    Cancer; 2005 Jan 15; 103(2):368-76. PubMed ID: 15599932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.